Skip to content

Inferior Alveolar Nerve Lateralization With Simultaneous Implant Placement Versus the Use of Short Dental Implants

Inferior Alveolar Nerve Lateralization With Simultaneous Implant Placement Versus the Use of Short Dental Implants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03661658
Enrollment
8
Registered
2018-09-07
Start date
2018-09-30
Completion date
2019-06-30
Last updated
2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Marginal Bone Loss, Primary Stability of the Implants

Brief summary

Assess the long term stability of short dental implants in comparison to standard implants inserted simultaneously with inferior alveolar nerve lateralization.

Interventions

PROCEDUREUsing short dental implant

Using short dental implant for patients with atrophic posterior mandible.

PROCEDUREInferior alveolar nerve lateralization with simultaneous implant placement

Inferior alveolar nerve lateralization with simultaneous implant placement in atrophic posterior mandible.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult patients with edentulous posterior mandible. * Both sexes. * No intraoral soft and hard tissue pathology. * No systemic condition that contraindicate implant placement. * Residual alveolar bone width longer than 6 mm height (7-9 mm).

Exclusion criteria

* Presence of fenestrations or dehiscence of the residual ridge. * Heavy smokers more than 20 cigarettes per day .(24) * Patients with systemic disease that may affect normal healing. * Psychiatric problems * Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.

Design outcomes

Primary

MeasureTime frameDescription
Primary stability3 monthsmeasuring the primary stability using the osstel

Secondary

MeasureTime frameDescription
Marginal bone loss3 monthsmeasuring the marginal bone loss by using CBCT

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026